Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tamsulosin adrenergic receptor alpha-1a NA Successful target TTD , DGIDB prostatitis[MeSHID:D011472]
Urination[MeSHID:D014554]
Ureterolithiasis[MeSHID:D053039]
Off-Label Use[MeSHID:D056687]
Ureteral Calculi[MeSHID:D014514]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.18 approved unknown
tamsulosin alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB prostatitis[MeSHID:D011472]
Urination[MeSHID:D014554]
Ureterolithiasis[MeSHID:D053039]
Off-Label Use[MeSHID:D056687]
Ureteral Calculi[MeSHID:D014514]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.18 approved,investigational antagonist
tamsulosin adrenergic receptor alpha-1a NA Successful target TTD , DGIDB prostatitis[MeSHID:D011472]
Urination[MeSHID:D014554]
Ureterolithiasis[MeSHID:D053039]
Off-Label Use[MeSHID:D056687]
Ureteral Calculi[MeSHID:D014514]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.18 approved antagonist
tamsulosin alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB prostatitis[MeSHID:D011472]
Urination[MeSHID:D014554]
Ureterolithiasis[MeSHID:D053039]
Off-Label Use[MeSHID:D056687]
Ureteral Calculi[MeSHID:D014514]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.22 approved,investigational antagonist
tamsulosin alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB prostatitis[MeSHID:D011472]
Urination[MeSHID:D014554]
Ureterolithiasis[MeSHID:D053039]
Off-Label Use[MeSHID:D056687]
Ureteral Calculi[MeSHID:D014514]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.26 approved,investigational antagonist
click here to return to the previous page